Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 51

    1.

    Effect of inhibition of the adrenomedullin gene on the growth and chemosensitivity of ovarian cancer cells.

    Chen P, Pang X, Zhang Y, He Y.

    Oncol Rep. 2012 May;27(5):1461-6. doi: 10.3892/or.2012.1655. Epub 2012 Jan 26.

    PMID:
    22294191
    [PubMed - in process]
    2.

    53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway.

    Hong S, Li X, Zhao Y, Yang Q, Kong B.

    Oncol Rep. 2012 Apr;27(4):1251-7. doi: 10.3892/or.2012.1641. Epub 2012 Jan 18.

    PMID:
    22266878
    [PubMed - indexed for MEDLINE]
    3.

    Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells.

    Jakubowska-Mućka A, Sieńko J, Zapała Ł, Wolny R, Lasek W.

    Oncol Rep. 2012 Apr;27(4):1245-50. doi: 10.3892/or.2012.1639. Epub 2012 Jan 16.

    PMID:
    22266802
    [PubMed - indexed for MEDLINE]
    4.

    Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer.

    Wang Y, Wang Y, Shen L, Pang Y, Qiao Z, Liu P.

    Oncol Rep. 2012 Apr;27(4):1156-62. doi: 10.3892/or.2012.1638. Epub 2012 Jan 16.

    PMID:
    22266777
    [PubMed - indexed for MEDLINE]
    5.

    Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

    Peng DX, Luo M, Qiu LW, He YL, Wang XF.

    Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.

    PMID:
    22246341
    [PubMed - indexed for MEDLINE]
    6.

    Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.

    Wu B, Hu K, Li S, Zhu J, Gu L, Shen H, Hambly BD, Bao S, Di W.

    Oncol Rep. 2012 Jan;27(1):101-8. doi: 10.3892/or.2011.1505. Epub 2011 Oct 13.

    PMID:
    22025319
    [PubMed - indexed for MEDLINE]
    7.

    Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.

    Brun JL, Cortez A, Lesieur B, Uzan S, Rouzier R, Daraï E.

    Oncol Rep. 2012 Apr;27(4):1049-57. doi: 10.3892/or.2011.1608. Epub 2011 Dec 22.

    PMID:
    22200690
    [PubMed - indexed for MEDLINE]
    8.

    Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.

    Sheng XJ, Zhou YQ, Song QY, Zhou DM, Liu QC.

    Oncol Rep. 2012 Apr;27(4):1011-8. doi: 10.3892/or.2011.1596. Epub 2011 Dec 19.

    PMID:
    22200669
    [PubMed - indexed for MEDLINE]
    9.

    Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.

    Zhu J, Hua K, Sun H, Yu Y, Jin H, Feng Y.

    Oncol Rep. 2011 Dec;26(6):1497-503. doi: 10.3892/or.2011.1430. Epub 2011 Aug 24.

    PMID:
    21874257
    [PubMed - indexed for MEDLINE]
    10.

    MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer.

    Hofstetter G, Berger A, Bauer EM, Schuster E, Wolf A, Chamson M, Müller-Holzner E, Reimer D, Braicu EI, Sehouli J, Ulmer H, Cacsire Castillo-Tong D, Zeillinger R, Concin N.

    Oncol Rep. 2012 Mar;27(3):673-7. doi: 10.3892/or.2011.1560. Epub 2011 Nov 23.

    PMID:
    22134502
    [PubMed - in process]
    11.

    Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.

    Liu P, Gou M, Yi T, Xie C, Qi X, Zhou S, Deng H, Wei Y, Zhao X.

    Oncol Rep. 2012 Feb;27(2):363-70. doi: 10.3892/or.2011.1550. Epub 2011 Nov 11.

    PMID:
    22086394
    [PubMed - indexed for MEDLINE]
    12.

    MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.

    Zhang H, Zuo Z, Lu X, Wang L, Wang H, Zhu Z.

    Oncol Rep. 2012 Feb;27(2):594-8. doi: 10.3892/or.2011.1530. Epub 2011 Nov 8.

    PMID:
    22076535
    [PubMed - indexed for MEDLINE]
    13.

    Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics.

    Lorkova L, Pospisilova J, Lacheta J, Leahomschi S, Zivny J, Cibula D, Zivny J, Petrak J.

    Oncol Rep. 2012 Feb;27(2):318-24. doi: 10.3892/or.2011.1513. Epub 2011 Oct 21.

    PMID:
    22020625
    [PubMed - indexed for MEDLINE]
    14.

    Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.

    Guo Y, Fu P, Zhu H, Reed E, Remick SC, Petros W, Mueller MD, Yu JJ.

    Oncol Rep. 2012 Jan;27(1):286-92. doi: 10.3892/or.2011.1483. Epub 2011 Oct 3.

    PMID:
    21971700
    [PubMed - indexed for MEDLINE]
    15.

    Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.

    Zhou X, Zhao F, Wang ZN, Song YX, Chang H, Chiang Y, Xu HM.

    Oncol Rep. 2012 Feb;27(2):447-54. doi: 10.3892/or.2011.1482. Epub 2011 Oct 3.

    PMID:
    21971665
    [PubMed - indexed for MEDLINE]
    16.

    microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

    Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S, Leslie KK.

    Oncol Rep. 2011 Oct;26(4):995-1002. doi: 10.3892/or.2011.1372. Epub 2011 Jul 1.

    PMID:
    21725615
    [PubMed - indexed for MEDLINE]
    17.

    Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.

    Lee JY, Shin JY, Kim HS, Heo JI, Kho YJ, Kang HJ, Park SH, Lee JY.

    Oncol Rep. 2012 Jan;27(1):87-93. doi: 10.3892/or.2011.1460. Epub 2011 Sep 14.

    PMID:
    21922150
    [PubMed - indexed for MEDLINE]
    18.

    Molecular genetics and epidemiology of epithelial ovarian cancer (Review).

    Haruta S, Furukawa N, Yoshizawa Y, Tsunemi T, Nagai A, Kawaguchi R, Tanase Y, Yoshida S, Kobayashi H.

    Oncol Rep. 2011 Dec;26(6):1347-56. doi: 10.3892/or.2011.1456. Epub 2011 Sep 12. Review.

    PMID:
    21922146
    [PubMed - indexed for MEDLINE]
    19.

    Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling pathways.

    Yin J, Yu C, Yang Z, He JL, Chen WJ, Liu HZ, Li WM, Liu HT, Wang YX.

    Oncol Rep. 2011 Sep;26(3):671-9. doi: 10.3892/or.2011.1334. Epub 2011 May 31.

    PMID:
    21637924
    [PubMed - indexed for MEDLINE]
    20.

    Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.

    Qi X, Song X, Liu P, Yi T, Li S, Xie C, Zheng Y, Bai Y, Sun C, Wei Y, Zhao X.

    Oncol Rep. 2011 Sep;26(3):703-10. doi: 10.3892/or.2011.1337. Epub 2011 Jun 6.

    PMID:
    21667029
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk